October 31, 2016
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced the initiation of SERENE, a Phase II study with pimavanserin for the treatment of...
May 10, 2016
Which companies have the heaviest weight in the SPDR S&P Biotechnology ETF
April 3, 2016
Gaining over 30 percent for the week were ACADIA Pharmaceuticals, Galena Biopharma, Hasen Medical , Cardiovascular Systems, and Vivus Inc